𝛼SK or Searchbullish
Artrya (ASX:AYA): Initiation of coverage; $2.35 price target; 5.1x current share price; Salix is a cloud-base
SUMMARY
- Cloud-base, AI-driven cardiac imaging diagnostics Artrya is the Perth-based developer of Salix, a cloud-based, AI-driven imaging diagnostic tool that integrates with the existing imaging systems used in hospitals and clinics to more quickly and accurately analyse and report on the condition of a patient’s coronary arteries.
- The integration of Salix's comprehensive workflow into healthcare centres' existing systems allows clinicians to analyse, annotate, edit, share, triage and write diagnostic reports all within a single interface.
- Salix's workflow provides a platform on which Artrya can roll out new products, and once installed and integrated into a hospital or clinic's workflow is a highly sticky and difficult to dislodge.
Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
- Unlock research summaries
- Follow top, independent analysts
- Receive personalised alerts
- Access Analytics, Events and more
Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.
Upgrade later to our paid plans for full-access.
or
Already have an account? Sign In Now
Discussions
(Paid Plans Only)
Price Chart(Sign Up to Access)
- Artrya (ASX:AYA): Initiation of coverage; $2.35 price target; 5.1x current share price; Salix is a cloud-base08 Feb 2026
x